Neurocrine Biosciences Announces initiation of Pha...
Category : Clinical Trial Update 1 July 2025Overview Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of a Phase 1...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Actinogen confirms 100th participant in XanaMIA ph...
Category : Clinical Trial Update 1 July 2025Overview With the 100th participant enrolled in the XanaMIA trial, the timeline for the planned i...
Argenx Advances Clinical Development of ARGX-119 i...
Category : Clinical Trial Update 30 June 2025Overview argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improv...
Bavarian Nordic initiates clinical trials of mpox...
Category : Clinical Trial Update 30 June 2025Overview Bavarian Nordic A/S, a global vaccine company with a mission to improve health and save...
GEMZ Phase 3 study of fenfluramine shows positive...
Category : Clinical Trial Update 30 June 2025Overview UCB, a global biopharmaceutical company, today announced that the Phase 3 study investig...
Latest Newsletter Post
-
Actinogen confirms 100th participan..
1 July 2025
-
Neurocrine Biosciences Announces in..
1 July 2025
-
Nicox Announces Last Patient Comple..
30 June 2025
-
GEMZ Phase 3 study of fenfluramine..
30 June 2025
-
Bavarian Nordic initiates clinical..
30 June 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com